Full-Time

Product Safety and Risk Manager

Software Systems Engineering

Posted on 9/25/2025

Philips

Philips

Manufactures sleep therapy and respiratory devices

No salary listed

Bengaluru, Karnataka, India

Hybrid

Office-based teams are required to work in-person at least 3 days per week.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Risk Management
Data Analysis
Requirements
  • Bachelor's/Master's Degree in Medical Sciences, Engineering, Life or Physical Science, Computer Science/Software development or equivalent.
  • Minimum 15+ years of experience with Bachelor's OR Minimum 5+ years of experience with Master's in areas such as Medical Device Product Development, Post Market Surveillance, Quality Engineering or equivalent.
  • Familiarity with safety risk management principles in accordance with 10 + years of experience including: FDA, 21 CFR Parts 803, 806, 820, ISO 13485, ISO 14971, ISO 9001, European Medical Device Directive (93/42/EEC), EU MDR.
  • Ability to work within a Quality Management System (QMS), with proficiency in contributing to the evolution of processes that meet regulatory requirements while remaining efficient and aligned with business goals.
  • Mandatory expertise in Complaint Handling, Vigilance Reporting, and Post-Market Surveillance (PMS) with awareness of global timelines.
  • Familiarity with tools such as Trackwise, Service Management Tools, and Analytics/KPI Dashboards.
  • Understanding of ISO 14971 Risk Management, CAPA processes, and product lifecycle safety.
Responsibilities
  • Oversees the product development cross-functional team responsible for developing all risk management deliverables for one or more products throughout its' lifecycle.
  • Reviews post-market product risk assessments to ensure ongoing product safety and compliance, participates in teams developing mitigations for potential hazards or issues that may arise, and facilitates risk mitigation strategies to uphold product integrity and safeguard patient, user, and consumer safety.
  • Provides advanced business-level guidance on product hazards and harms and collaborates with medical affairs to ensure identification of harms and alignment with applicable regulations and standards, aiming to mitigate risks and safeguard product integrity and patient, user and consumer safety.
  • Owns multiple products, requiring efficient management and coordination across various teams and stakeholders to ensure comprehensive risk management strategies are implemented effectively throughout each product's lifecycle.
  • Analyzes key performance indicators (KPIs) pertaining to product risk management processes, facilitating informed decision-making and strategic planning within the department to ensure optimal performance and compliance with regulatory standards.
  • Owns medium-to-complex inquiries into product-related incidents or failures, ensures thorough investigations, and effectively communicates risk findings and recommendations to senior management for informed decision-making and ensure that proactive risk mitigation strategies are developed to maintain patient, user, and consumer safety.
  • Manages process improvement initiatives to drive best in class efficiency and effectiveness in risk management.
  • Develops and executes risk control measures to effectively minimize potential negative outcomes and enhance overall product safety and reliability.
  • Manages initiatives to improve both internal and external risk communication strategies with stakeholders and customers, and actively engages in industry conferences, forums, and working groups to remain updated on evolving best practices and emerging trends in product risk management.
  • Coordinate with Engineering and Medical Affairs to maintain safety documentation and risk controls.
  • Monitor post-market data (e.g., complaints, CAPAs, NCRs, customer feedback) for safety implications.
  • Failure and Safety Analysis: Evaluate system failures to identify potential safety risks and swiftly perform safety analyses on defects discovered within the ISCV system.
  • Use Analysis: Examine the standard usage patterns of the ISCV cardiology information system for possible safety risks with full understanding of the intended use of the system.
  • Risk Assessment: Conduct a systematic assessment of safety risks, categorizing them by hazard, harm, probability of occurrence (P1), probability of harm (P2), and severity.
  • Risk Control Contribution: Collaborate with cross-functional teams to define and implement effective risk control measures.
  • Documentation Management: Maintain comprehensive safety documentation within the design history file of the device in close cooperation with project core teams, ensuring coherence with project goals and facilitating easy access for auditing purposes.

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE